|
|
Gene Symbol |
IGF2R |
|
Aliases |
CD222, CI-M6PR, CIMPR, M6P-R, M6P/IGF2R, MPR 300, MPR1, MPR300, MPRI |
|
Entrez Gene ID |
|
|
Gene Name |
Insulin like growth factor 2 receptor |
|
Chromosomal Location |
6q25.3 |
|
HGNC ID |
|
|
Summary |
This gene encodes a receptor for both insulin-like growth factor 2 and mannose 6-phosphate. The binding sites for each ligand are located on different segments of the protein. This receptor has various functions, including in the intracellular trafficking of lysosomal enzymes, the activation of transforming growth factor beta, and the degradation of insulin-like growth factor 2. Mutation or loss of heterozygosity of this gene has been association with risk of hepatocellular carcinoma. The orthologous mouse gene is imprinted and shows exclusive expression from the maternal allele; however, imprinting of the human gene may be polymorphic, as only a minority of individuals showed biased expression from the maternal allele (PMID:8267611). [provided by RefSeq, Nov 2015]
|
|
RefSeq DNA |
|
|
RefSeq mRNA |
|
|
e!Ensembl
|
Protein Information |
|
Protein Name |
Cation-independent mannose-6-phosphate receptor, 300 kDa mannose 6-phosphate receptor, CI Man-6-P receptor, IGF-II receptor, M6P/IGF2 receptor, insulin-like growth factor II receptor |
|
Function |
Transport of phosphorylated lysosomal enzymes from the Golgi complex and the cell surface to lysosomes. Lysosomal enzymes bearing phosphomannosyl residues bind specifically to mannose-6-phosphate receptors in the Golgi apparatus and the resulting receptor-ligand complex is transported to an acidic prelyosomal compartment where the low pH mediates the dissociation of the complex. This receptor also binds IGF2. Acts as a positive regulator of T-cell coactivation, by binding DPP4. |
|
|
|
|
|
UniProt |
|
|
PDB |
1JWG, 1JPL, 1LF8, 2L29, 2V5P, 1E6F, 1GP0, 1GP3, 1GQB, 2CNJ, 2L2A, 2M68, 2M6T, 2V5N, 2V5O, 5IEI |
|
|
|
Interactions |
| |
STRING |
MINT |
IntAct |
ENSP00000398698 |
P01375 |
P01375 |
|
| |
View interactions
|
|
| |
Associated Diseases
Disease group | Disease Name | References |
Cardiovascular Diseases |
Arteriosclerosis |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities |
Congenital diaphragmatic hernia |
|
Endocrine System Diseases |
PCOS |
|
Neoplasms |
Prostate cancer |
|
Liver Cancer |
|
Nervous System Diseases |
Parkinson Disease |
|
Psychiatric/Brain disorders |
Lewy Body Disease |
|
Alzheimer Disease |
|
Senile Dementia |
|
|
References |
|
|
|
PubMed ID |
Associated gene/s |
Associated condition |
Genetic Mutation |
Diagnostic Criteria |
Association with PCOS |
Ethnicity |
Conclusion |
|
Epidermal growth factor-like (EGFR, EREG and AREG),IGF-like families (IGF1R, IGF2R, IGF2BP2 and IGFBP2),CYP11A1, CYP1B1, CYP19A1 and CYP2B7P1 |
Abnormal folliculogenesis and reduced oocyte competence |
|
Rotterdam Criteria |
Related
|
|
Specifically, CCs from women with PCOS were characterized by abnormal expression of many growth factors, including members of the epidermal growth factor-like (EGFR, EREG and AREG) and IGF-like families (IGF1R, IGF2R, IGF2BP2 and IGFBP2), that are known to play a role in oocyte competence. |
|
|
|
|